Economic Impact Linked To the Reduction of Exacerbations When A Treatment Regime With Inhaled Antibiotics Is Switched To Aztreonam Lysine In Patients With Cystic Fibrosis and Chronic Pulmonary Infection Caused By Pseudomonas Aeruginosa
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1659
https://www.valueinhealthjournal.com/article/S1098-3015(14)03589-X/fulltext
Title :
Economic Impact Linked To the Reduction of Exacerbations When A Treatment Regime With Inhaled Antibiotics Is Switched To Aztreonam Lysine In Patients With Cystic Fibrosis and Chronic Pulmonary Infection Caused By Pseudomonas Aeruginosa
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03589-X&doi=10.1016/j.jval.2014.08.1659
First page :
A526
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1136